Compare · ALB vs WLKP
ALB vs WLKP
Side-by-side comparison of Albemarle Corporation (ALB) and Westlake Chemical Partners LP (WLKP): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ALB and WLKP operate in Major Chemicals (Industrials), so they compete in similar markets.
- ALB is the larger of the two at $14.24B, about 18.4x WLKP ($775.8M).
- Over the past year, ALB is up 53.1% and WLKP is up 0.4% - ALB leads by 52.6 points.
- ALB has hit the wire 10 times in the past 4 weeks while WLKP has been quiet.
- ALB has more recent analyst coverage (25 ratings vs 2 for WLKP).
- Company
- Albemarle Corporation
- Westlake Chemical Partners LP
- Price
- $118.10-2.10%
- $22.11+0.16%
- Market cap
- $14.24B
- $775.8M
- 1M return
- -29.08%
- -4.43%
- 1Y return
- +53.06%
- +0.41%
- Industry
- Major Chemicals
- Major Chemicals
- Exchange
- NYSE
- NYSE
- IPO
- 2014
- News (4w)
- 10
- 0
- Recent ratings
- 25
- 2
Albemarle Corporation
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine Specialties, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets. It also provides cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for pyrotechnical applications; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Bromine Specialties segment offers bromine and bromine-based fire safety solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines, biocides, disinfectants, and sanitizers. The Catalysts segment provides hydroprocessing, isomerization, and akylation catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, crop protection, and custom chemistry services markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.
Westlake Chemical Partners LP
Westlake Chemical Partners LP acquires, develops, and operates ethylene production facilities and related assets in the United States. The company's ethylene production facilities primarily convert ethane into ethylene. It also sells ethylene co-products, including propylene, crude butadiene, pyrolysis gasoline, and hydrogen directly to third parties on a spot or contract basis. Westlake Chemical Partners GP LLC serves as the general partner of the company. The company was founded in 2014 and is headquartered in Houston, Texas.
Latest ALB
- Albemarle Corporation to Release Second Quarter 2026 Earnings Results on Wednesday, August 5, 2026
- Director Collins Michelle T was granted 1,252 shares, increasing direct ownership by 385% to 1,577 units (SEC Form 4)
- SEC Form 4 filed by Director Minor Glenda J
- Director Brlas Laurie was granted 1,286 shares, increasing direct ownership by 21% to 7,289 units (SEC Form 4)
- Director Cramer Ralf Hans covered exercise/tax liability with 942 shares and was granted 1,286 shares, increasing direct ownership by 6% to 5,723 units (SEC Form 4)
- Director Wolff Alejandro Daniel was granted 33 shares, increasing direct ownership by 0.25% to 13,044 units (SEC Form 4)
- SEC Form 4 filed by Director Widmar Mark R
- Director Steiner Gerald A was granted 1,286 shares, increasing direct ownership by 11% to 13,232 units (SEC Form 4)
- SEC Form 4 filed by Director Van Deursen Holly
- Director Oconnell Diarmuid B. was granted 1,286 shares, increasing direct ownership by 18% to 8,626 units (SEC Form 4)
Latest WLKP
- SEC Form 3 filed by new insider Baksht Jonathan
- SEC Form 10-Q filed by Westlake Chemical Partners LP
- Westlake Chemical Partners LP filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- Westlake Chemical Partners LP Announces First Quarter 2026 Results
- Westlake Chemical Partners LP Announces First Quarter 2026 Distribution
- Westlake Chemical Partners Announce First Quarter 2026 Conference Call
- SEC Form 8-K filed by Westlake Chemical Partners LP
- Westlake Chemical Partners Appoints Jonathan H. Baksht as Senior Vice President and Chief Financial Officer
- SEC Form S-3 filed by Westlake Chemical Partners LP
- Westlake Chemical Partners LP Filed Annual Report